To evaluate the beneficial effect of OM-MSCs on epilepsy, mouse OM-MSCs were isolated from turbinal of mouse and characterized as CD45-, CD34-, and CD31-negative and CD105-, CD90-, and CD73-positive (Additional file 3: Fig. S3). This evidence concerns the gene PTPRC and epilepsy.